Back
Neurocrine Biosciences Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
NBIX
Neurocrine Biosciences
Last Price:
$113.24
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.21 | Sell |
| 20-day SMA: | 112.44 | Buy |
| 50-day SMA: | 125.75 | Sell |
| 200-day SMA: | 129.92 | Sell |
| 8-day EMA: | 113.36 | Sell |
| 20-day EMA: | 114.36 | Sell |
| 50-day EMA: | 120.64 | Sell |
| 200-day EMA: | 127.22 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.52 | Sell |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | -89756 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.18 - 116.76) | Sell |
| Bollinger Bands (100): | (114.96 - 140.2) | Sell |
Neurocrine Biosciences Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 113.16 while NBIX 8-day simple moving average is 113.21, which is a Sell signal.
-
The stock price of NBIX is 113.16 while Neurocrine Biosciences 20-day SMA is 112.44, which makes it a Buy.
-
Neurocrine Biosciences 50-day simple moving average is 125.75 while NBIX share price is 113.16, making it a Sell technically.
-
NBIX stock price is 113.16 and Neurocrine Biosciences 200-day simple moving average is 129.92, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
40
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a SellThe current Neurocrine Biosciences [NBIX] share price is $113.16. The Score for NBIX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
11.3B
Price in USD:
113.16
Share Volume:
800.8K
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
105.18
Sell
40
Neurocrine Biosciences (NBIX)
is a Sell
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 113.16 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 113.16 while NBIX 8-day exponential moving average is 113.36, which is a Sell signal.
-
The stock price of NBIX is 113.16 while Neurocrine Biosciences 20-day EMA is 114.36, which makes it a Sell.
-
Neurocrine Biosciences 50-day exponential moving average is 120.64 while NBIX share price is 113.16, making it a Sell technically.
-
NBIX stock price is 113.16 and Neurocrine Biosciences 200-day simple moving average is 127.22, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.54 per share, a decrease this year of $0.28 per share, and an increase next year of $2.62 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -2.52, suggesting Neurocrine Biosciences is a Sell
-
Neurocrine Biosciences Relative Strength Index (RSI) is 44.16, which suggest Neurocrine Biosciences is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences is (110.18 - 116.76), which suggest Neurocrine Biosciences is a Sell
-
The Bollinger Bands (100) for Neurocrine Biosciences is (114.96 - 140.2), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.